Handong Sun

Title: Handong Sun: Innovator in Pharmaceutical Chemistry

Introduction

Handong Sun is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with potential applications in cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Handong Sun holds a patent for a compound of Formula I or its pharmaceutically acceptable salt and its preparation method and applications. This compound, which has not been reported in literature, is isolated from a specific source and serves as a Trx1 selective inhibitor. The invention further discloses a pharmaceutical composition and the preparation of the compound of Formula I, highlighting its applications in developing medicines for preventing or treating cancer. The compound, referred to as Iso A, boasts advantages such as low toxicity, high safety, and strong pharmacological effects, suggesting a promising future in pharmaceutical applications. He has 1 patent to his name.

Career Highlights

Handong Sun is affiliated with the Jiangsu Province Institute of Traditional Chinese Medicine, where he conducts research and development in traditional and modern medicinal practices. His work emphasizes the integration of traditional knowledge with contemporary scientific methods to create effective therapeutic solutions.

Collaborations

Handong Sun collaborates with notable colleagues, including Peng Cao and Jianxin Pu, who contribute to his research endeavors and enhance the impact of his work in the field.

Conclusion

Handong Sun's innovative contributions to pharmaceutical chemistry, particularly in cancer treatment, underscore his role as a leading inventor in the industry. His patent reflects a commitment to advancing medical science and improving patient outcomes.